A novel prenylflavonoid with efficacy in cancer therapy by targeting ceramide-orchestrated signaling.

Du R, Zhang C, Lei H, Gao X, Xiang Q, Zhang Z, Dai Y, Li X, Zhang L, Chen G

Open source

DOI
10.3389/fphar.2026.1862457
Published
2026
Container
Frontiers in pharmacology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1862457,
  title = {A novel prenylflavonoid with efficacy in cancer therapy by targeting ceramide-orchestrated signaling.},
  author = {Du R and Zhang C and Lei H and Gao X and Xiang Q and Zhang Z and Dai Y and Li X and Zhang L and Chen G},
  year = {2026},
  journal = {Frontiers in pharmacology},
  doi = {10.3389/fphar.2026.1862457},
  url = {https://doi.org/10.3389/fphar.2026.1862457}
}

RIS

TY  - JOUR
TI  - A novel prenylflavonoid with efficacy in cancer therapy by targeting ceramide-orchestrated signaling.
AU  - Du R
AU  - Zhang C
AU  - Lei H
AU  - Gao X
AU  - Xiang Q
AU  - Zhang Z
AU  - Dai Y
AU  - Li X
AU  - Zhang L
AU  - Chen G
PY  - 2026
JO  - Frontiers in pharmacology
DO  - 10.3389/fphar.2026.1862457
UR  - https://doi.org/10.3389/fphar.2026.1862457
ER  - 

APA

R, D., C, Z., H, L., X, G., Q, X., Z, Z., Y, D., X, L., L, Z., & G, C. (2026). A novel prenylflavonoid with efficacy in cancer therapy by targeting ceramide-orchestrated signaling.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2026.1862457

Source records